Target intelligence / Profile preview

Murine Double Minute 2 (MDM2)

Target
MDM2
Molecular classification
E3 ubiquitin-protein ligase, Enzyme
01

Overview

Murine double minute 2 (MDM2), also known as E3 ubiquitin-protein ligase Mdm2, is a key regulatory protein that primarily functions as an E3 ubiquitin ligase targeting the tumor suppressor p53 for proteasomal degradation. MDM2 inhibits p53's transcriptional activity, promoting its ubiquitination. Overexpression or amplification of MDM2 has been observed in various cancers, disabling the tumor-suppressive functions of p53. Beyond p53 regulation, MDM2 can also target other proteins contributing to cell proliferation and survival. Due to its central role in cancer progression, antagonists targeting the interaction between MDM2 and p53 are under active investigation as anti-cancer therapies.

Other names
E3 ubiquitin-protein ligase Mdm2Hdm2 (human homolog)MDM₂
02

Mechanism of action

Inhibition of MDM2-p53 interaction, leading to p53 activation and downstream tumor-suppressive effects.

03

Biological functions

Negative regulator of p53Cell cycle regulationApoptosisDNA repairCellular senescenceCell proliferationUbiquitinationImmune response regulationDifferentiation
04

Disease associations

CancerSoft tissue sarcomasOsteosarcomasBreast tumorsAcute myeloid leukemia (AML)
05

Safety considerations

Potential for off-target effectsDevelopment of resistanceToxicity related to p53 activation in normal cells
06

Interacting drugs

Nutlin-3a

1 more in the full profile.

07

Biomarkers

MDM2 expression levelsp53 status

Beyond the preview

Go deeper on Murine Double Minute 2 (MDM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Murine Double Minute 2 (MDM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call